
The global Pulmonary Function Testing Systems market size was US$ 433 million in 2024 and is forecast to a readjusted size of US$ 575 million by 2031 with a CAGR of 4.2% during the forecast period 2025-2031.
Pulmonary Function Testing (PFT) is a complete evaluation of the respiratory system including patient history, physical examinations, chest x-ray examinations, arterial blood gas analysis, and tests of pulmonary function.
The primary purpose of pulmonary function testing is to identify the severity of pulmonary impairment. Pulmonary function testing has diagnostic and therapeutic roles and helps clinicians answer some general questions about patients with lung disease.
Global Pulmonary Function Testing Systems main players are CareFusion(BD), Schiller, MGC Diagnostics, M&B, etc. Global top five manufacturers hold a share about 50%. Europe is the largest market, with a share about 30.
The global Pulmonary Function Testing Systems market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
CareFusion(BD)
Schiller
CHEST
COSMED
nSpire Health
NDD
MGC Diagnostics
Minato
Ganshorn
AESRI
Morgan Scientific
M&B
Sikeda
RSDQ
By Type: (Dominant Segment vs High-Margin Innovation)
Portable PFT Systems
Complete PFT Systems
By Application: (Core Demand Driver vs Emerging Opportunity)
Hospitals
Physical Examination Center
Physician Groups
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., CareFusion(BD) in Europe)
- Emerging Product Trends: Portable PFT Systems adoption vs. Complete PFT Systems premiumization
- Demand-Side Dynamics: Hospitals growth in China vs. Physical Examination Center potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Pulmonary Function Testing Systems market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Complete PFT Systems in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Physical Examination Center in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Pulmonary Function Testing Systems value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Pulmonary Function Testing Systems Product Scope
1.2 Pulmonary Function Testing Systems by Type
1.2.1 Global Pulmonary Function Testing Systems Sales by Type (2020 & 2024 & 2031)
1.2.2 Portable PFT Systems
1.2.3 Complete PFT Systems
1.3 Pulmonary Function Testing Systems by Application
1.3.1 Global Pulmonary Function Testing Systems Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Hospitals
1.3.3 Physical Examination Center
1.3.4 Physician Groups
1.3.5 Others
1.4 Global Pulmonary Function Testing Systems Market Estimates and Forecasts (2020-2031)
1.4.1 Global Pulmonary Function Testing Systems Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Pulmonary Function Testing Systems Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Pulmonary Function Testing Systems Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Pulmonary Function Testing Systems Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Pulmonary Function Testing Systems Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Pulmonary Function Testing Systems Sales Market Share by Region (2020-2025)
2.2.2 Global Pulmonary Function Testing Systems Revenue Market Share by Region (2020-2025)
2.3 Global Pulmonary Function Testing Systems Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Pulmonary Function Testing Systems Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Pulmonary Function Testing Systems Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Pulmonary Function Testing Systems Market Size and Prospective (2020-2031)
2.4.2 Europe Pulmonary Function Testing Systems Market Size and Prospective (2020-2031)
2.4.3 China Pulmonary Function Testing Systems Market Size and Prospective (2020-2031)
2.4.4 Japan Pulmonary Function Testing Systems Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Pulmonary Function Testing Systems Historic Market Review by Type (2020-2025)
3.1.1 Global Pulmonary Function Testing Systems Sales by Type (2020-2025)
3.1.2 Global Pulmonary Function Testing Systems Revenue by Type (2020-2025)
3.1.3 Global Pulmonary Function Testing Systems Price by Type (2020-2025)
3.2 Global Pulmonary Function Testing Systems Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Pulmonary Function Testing Systems Sales Forecast by Type (2026-2031)
3.2.2 Global Pulmonary Function Testing Systems Revenue Forecast by Type (2026-2031)
3.2.3 Global Pulmonary Function Testing Systems Price Forecast by Type (2026-2031)
3.3 Different Types Pulmonary Function Testing Systems Representative Players
4 Global Market Size by Application
4.1 Global Pulmonary Function Testing Systems Historic Market Review by Application (2020-2025)
4.1.1 Global Pulmonary Function Testing Systems Sales by Application (2020-2025)
4.1.2 Global Pulmonary Function Testing Systems Revenue by Application (2020-2025)
4.1.3 Global Pulmonary Function Testing Systems Price by Application (2020-2025)
4.2 Global Pulmonary Function Testing Systems Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Pulmonary Function Testing Systems Sales Forecast by Application (2026-2031)
4.2.2 Global Pulmonary Function Testing Systems Revenue Forecast by Application (2026-2031)
4.2.3 Global Pulmonary Function Testing Systems Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Pulmonary Function Testing Systems Application
5 Competition Landscape by Players
5.1 Global Pulmonary Function Testing Systems Sales by Players (2020-2025)
5.2 Global Top Pulmonary Function Testing Systems Players by Revenue (2020-2025)
5.3 Global Pulmonary Function Testing Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pulmonary Function Testing Systems as of 2024)
5.4 Global Pulmonary Function Testing Systems Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Pulmonary Function Testing Systems, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Pulmonary Function Testing Systems, Product Type & Application
5.7 Global Key Manufacturers of Pulmonary Function Testing Systems, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Pulmonary Function Testing Systems Sales by Company
6.1.1.1 North America Pulmonary Function Testing Systems Sales by Company (2020-2025)
6.1.1.2 North America Pulmonary Function Testing Systems Revenue by Company (2020-2025)
6.1.2 North America Pulmonary Function Testing Systems Sales Breakdown by Type (2020-2025)
6.1.3 North America Pulmonary Function Testing Systems Sales Breakdown by Application (2020-2025)
6.1.4 North America Pulmonary Function Testing Systems Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Pulmonary Function Testing Systems Sales by Company
6.2.1.1 Europe Pulmonary Function Testing Systems Sales by Company (2020-2025)
6.2.1.2 Europe Pulmonary Function Testing Systems Revenue by Company (2020-2025)
6.2.2 Europe Pulmonary Function Testing Systems Sales Breakdown by Type (2020-2025)
6.2.3 Europe Pulmonary Function Testing Systems Sales Breakdown by Application (2020-2025)
6.2.4 Europe Pulmonary Function Testing Systems Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Pulmonary Function Testing Systems Sales by Company
6.3.1.1 China Pulmonary Function Testing Systems Sales by Company (2020-2025)
6.3.1.2 China Pulmonary Function Testing Systems Revenue by Company (2020-2025)
6.3.2 China Pulmonary Function Testing Systems Sales Breakdown by Type (2020-2025)
6.3.3 China Pulmonary Function Testing Systems Sales Breakdown by Application (2020-2025)
6.3.4 China Pulmonary Function Testing Systems Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Pulmonary Function Testing Systems Sales by Company
6.4.1.1 Japan Pulmonary Function Testing Systems Sales by Company (2020-2025)
6.4.1.2 Japan Pulmonary Function Testing Systems Revenue by Company (2020-2025)
6.4.2 Japan Pulmonary Function Testing Systems Sales Breakdown by Type (2020-2025)
6.4.3 Japan Pulmonary Function Testing Systems Sales Breakdown by Application (2020-2025)
6.4.4 Japan Pulmonary Function Testing Systems Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 CareFusion(BD)
7.1.1 CareFusion(BD) Company Information
7.1.2 CareFusion(BD) Business Overview
7.1.3 CareFusion(BD) Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2020-2025)
7.1.4 CareFusion(BD) Pulmonary Function Testing Systems Products Offered
7.1.5 CareFusion(BD) Recent Development
7.2 Schiller
7.2.1 Schiller Company Information
7.2.2 Schiller Business Overview
7.2.3 Schiller Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Schiller Pulmonary Function Testing Systems Products Offered
7.2.5 Schiller Recent Development
7.3 CHEST
7.3.1 CHEST Company Information
7.3.2 CHEST Business Overview
7.3.3 CHEST Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2020-2025)
7.3.4 CHEST Pulmonary Function Testing Systems Products Offered
7.3.5 CHEST Recent Development
7.4 COSMED
7.4.1 COSMED Company Information
7.4.2 COSMED Business Overview
7.4.3 COSMED Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2020-2025)
7.4.4 COSMED Pulmonary Function Testing Systems Products Offered
7.4.5 COSMED Recent Development
7.5 nSpire Health
7.5.1 nSpire Health Company Information
7.5.2 nSpire Health Business Overview
7.5.3 nSpire Health Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2020-2025)
7.5.4 nSpire Health Pulmonary Function Testing Systems Products Offered
7.5.5 nSpire Health Recent Development
7.6 NDD
7.6.1 NDD Company Information
7.6.2 NDD Business Overview
7.6.3 NDD Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2020-2025)
7.6.4 NDD Pulmonary Function Testing Systems Products Offered
7.6.5 NDD Recent Development
7.7 MGC Diagnostics
7.7.1 MGC Diagnostics Company Information
7.7.2 MGC Diagnostics Business Overview
7.7.3 MGC Diagnostics Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2020-2025)
7.7.4 MGC Diagnostics Pulmonary Function Testing Systems Products Offered
7.7.5 MGC Diagnostics Recent Development
7.8 Minato
7.8.1 Minato Company Information
7.8.2 Minato Business Overview
7.8.3 Minato Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Minato Pulmonary Function Testing Systems Products Offered
7.8.5 Minato Recent Development
7.9 Ganshorn
7.9.1 Ganshorn Company Information
7.9.2 Ganshorn Business Overview
7.9.3 Ganshorn Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Ganshorn Pulmonary Function Testing Systems Products Offered
7.9.5 Ganshorn Recent Development
7.10 AESRI
7.10.1 AESRI Company Information
7.10.2 AESRI Business Overview
7.10.3 AESRI Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2020-2025)
7.10.4 AESRI Pulmonary Function Testing Systems Products Offered
7.10.5 AESRI Recent Development
7.11 Morgan Scientific
7.11.1 Morgan Scientific Company Information
7.11.2 Morgan Scientific Business Overview
7.11.3 Morgan Scientific Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Morgan Scientific Pulmonary Function Testing Systems Products Offered
7.11.5 Morgan Scientific Recent Development
7.12 M&B
7.12.1 M&B Company Information
7.12.2 M&B Business Overview
7.12.3 M&B Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2020-2025)
7.12.4 M&B Pulmonary Function Testing Systems Products Offered
7.12.5 M&B Recent Development
7.13 Sikeda
7.13.1 Sikeda Company Information
7.13.2 Sikeda Business Overview
7.13.3 Sikeda Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Sikeda Pulmonary Function Testing Systems Products Offered
7.13.5 Sikeda Recent Development
7.14 RSDQ
7.14.1 RSDQ Company Information
7.14.2 RSDQ Business Overview
7.14.3 RSDQ Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2020-2025)
7.14.4 RSDQ Pulmonary Function Testing Systems Products Offered
7.14.5 RSDQ Recent Development
8 Pulmonary Function Testing Systems Manufacturing Cost Analysis
8.1 Pulmonary Function Testing Systems Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Pulmonary Function Testing Systems
8.4 Pulmonary Function Testing Systems Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Pulmonary Function Testing Systems Distributors List
9.3 Pulmonary Function Testing Systems Customers
10 Pulmonary Function Testing Systems Market Dynamics
10.1 Pulmonary Function Testing Systems Industry Trends
10.2 Pulmonary Function Testing Systems Market Drivers
10.3 Pulmonary Function Testing Systems Market Challenges
10.4 Pulmonary Function Testing Systems Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
CareFusion(BD)
Schiller
CHEST
COSMED
nSpire Health
NDD
MGC Diagnostics
Minato
Ganshorn
AESRI
Morgan Scientific
M&B
Sikeda
RSDQ
Ìý
Ìý
*If Applicable.
